On February 5, Gelonghui Medical (603716.SH) announced that the company plans to repurchase the company's shares through centralized bidding transactions; the total repurchase capital shall not be less than RMB 10 million (inclusive) and not more than RMB 20 million, and the repurchase price shall not exceed RMB 12.16 per share (inclusive).
塞力医疗(603716.SH)：拟斥资1000万元到2000万元回购股份
Saili Healthcare (603716.SH): Plans to spend 10 million yuan to 20 million yuan to buy back shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.